DTIL
Precision BioSciencesANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
DTIL vs peer average
92/100
DTIL vs. peer average (A vs. D)
Grade spread
A 1 · B 2 · C 1 · D 2 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
BEAM is the first available peer comparator.
Beam Therapeutics is a closer gene-editing-platform comparator than the same-market-cap peer list because investor sentiment is driven by clinical editing proof, safety, durability, and cash runway; it is still not a direct HBV or DMD indication match.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
DTIL
Precision BioSciences
BEAM
Beam Therapeutics
Grade
A
B
Momentum
86
76
Value
44
41
Sentiment
75
66
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs BEAM
DTIL / BEAM
Grade Position
Above peers
DTIL vs. peer average (A vs. D)
92/100
Momentum
86
DTILValue
44
DTILSentiment
75
DTILRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs DTIL
BEAM is the first peer returned for this comparison set.